Search
for
Sort by
Research 571–600 of 876
- Different Patterns of Lichen Planus in Three Members of One Family
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Real-world evidence in alopecia areata treatment: A narrative review
- Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Establishing the financial burden of alopecia areata and its predictors
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Hair transplantation in androgenetic alopecia
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis
- Method to Identify Demodex in the Eyelash Follicle Without Epilation
- Isolated eyebrow and eyelash trichotillomania mimicking alopecia areata
- Eyelash Length in Children and Adolescents with Allergic Diseases
- Eyelash alopecia areata: case series and literature review
- Postburns hair restoration of eyebrow, eyelash, moustache, beard and scalp areas
- Hypothyroidism, eyelash loss
- Aesthetic Eyelash Elongation for Asians Using a Dense-Packing Single-Hair Grafting Technique
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- Treatment of Vitiligo Associated Eyebrow and Eyelash Leukotrichia - A Systematic Review of Existing Information
- Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
- Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata